6ZFG
14-3-3 zeta chimera with 18E6 and fusicoccin
Summary for 6ZFG
Entry DOI | 10.2210/pdb6zfg/pdb |
Related | 6ZFD |
Descriptor | 14-3-3 protein zeta/delta,Protein E6, GLYCEROL, FUSICOCCIN, ... (4 entities in total) |
Functional Keywords | 14-3-3, hpv, e6 oncoprotein, protein binding |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 2 |
Total formula weight | 56243.27 |
Authors | Gogl, G.,Tugaeva, K.,Sluchanko, N.N.,Trave, G. (deposition date: 2020-06-17, release date: 2021-02-17, Last modification date: 2024-10-23) |
Primary citation | Gogl, G.,Tugaeva, K.V.,Eberling, P.,Kostmann, C.,Trave, G.,Sluchanko, N.N. Hierarchized phosphotarget binding by the seven human 14-3-3 isoforms. Nat Commun, 12:1677-1677, 2021 Cited by PubMed Abstract: The seven 14-3-3 isoforms are highly abundant human proteins encoded by similar yet distinct genes. 14-3-3 proteins recognize phosphorylated motifs within numerous human and viral proteins. Here, we analyze by X-ray crystallography, fluorescence polarization, mutagenesis and fusicoccin-mediated modulation the structural basis and druggability of 14-3-3 binding to four E6 oncoproteins of tumorigenic human papillomaviruses. 14-3-3 isoforms bind variant and mutated phospho-motifs of E6 and unrelated protein RSK1 with different affinities, albeit following an ordered affinity ranking with conserved relative K ratios. Remarkably, 14-3-3 isoforms obey the same hierarchy when binding to most of their established targets, as supported by literature and a recent human complexome map. This knowledge allows predicting proportions of 14-3-3 isoforms engaged with phosphoproteins in various tissues. Notwithstanding their individual functions, cellular concentrations of 14-3-3 may be collectively adjusted to buffer the strongest phosphorylation outbursts, explaining their expression variations in different tissues and tumors. PubMed: 33723253DOI: 10.1038/s41467-021-21908-8 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.85 Å) |
Structure validation
Download full validation report